Ferroptosis-centered Disease Response Information
General Information of the Disease (ID: DIS00051)
| Name |
Hemangioma
|
||||
|---|---|---|---|---|---|
| ICD |
ICD-11: 2E81
|
||||
Full List of Target(s) of This Ferroptosis-centered Disease
Cystine/glutamate transporter (SLC7A11)
| In total 3 item(s) under this target | ||||
| Experiment 1 Reporting the Ferroptosis-centered Disease Response by This Target | [1] | |||
| Target for Ferroptosis | Suppressor | |||
| Responsed Disease | Hemangioma [ICD-11: 2E81] | |||
| Responsed Regulator | hsa-miR-497-5p (miRNA) | Driver | ||
| Pathway Response | Fatty acid metabolism | hsa01212 | ||
| Ferroptosis | hsa04216 | |||
| Notch signaling pathway | hsa04330 | |||
| Cell Process | Cell ferroptosis | |||
| Cell proliferation | ||||
| In Vitro Model | hHemECs (Human hemangioma endothelial cells) | |||
| Response regulation | Knockdown of long non-coding RNA MEG8 inhibited the proliferation and induced the ferroptosis of hemangioma endothelial cells by regulating miR-497-5p/NOTCH2 axis. Importantly, silencing MEG8 significantly decreased the expressions of SLC7A11 and GPX4 both in mRNA and protein level and had no effect on the level of AIFM2. | |||
| Experiment 2 Reporting the Ferroptosis-centered Disease Response by This Target | [1] | |||
| Target for Ferroptosis | Suppressor | |||
| Responsed Disease | Hemangioma [ICD-11: 2E81] | |||
| Responsed Regulator | Neurogenic locus notch homolog protein 2 (NOTCH2) | Suppressor | ||
| Pathway Response | Fatty acid metabolism | hsa01212 | ||
| Ferroptosis | hsa04216 | |||
| Notch signaling pathway | hsa04330 | |||
| Cell Process | Cell ferroptosis | |||
| Cell proliferation | ||||
| In Vitro Model | hHemECs (Human hemangioma endothelial cells) | |||
| Response regulation | Knockdown of long non-coding RNA MEG8 inhibited the proliferation and induced the ferroptosis of hemangioma endothelial cells by regulating miR-497-5p/ NOTCH2 axis. Importantly, silencing MEG8 significantly decreased the expressions of SLC7A11 and GPX4 both in mRNA and protein level and had no effect on the level of AIFM2. | |||
| Experiment 3 Reporting the Ferroptosis-centered Disease Response by This Target | [1] | |||
| Target for Ferroptosis | Suppressor | |||
| Responsed Disease | Hemangioma [ICD-11: 2E81] | |||
| Responsed Regulator | MEG8 (IncRNA) | Suppressor | ||
| Pathway Response | Fatty acid metabolism | hsa01212 | ||
| Ferroptosis | hsa04216 | |||
| Notch signaling pathway | hsa04330 | |||
| Cell Process | Cell ferroptosis | |||
| Cell proliferation | ||||
| In Vitro Model | hHemECs (Human hemangioma endothelial cells) | |||
| Response regulation | Knockdown of long non-coding RNA MEG8 inhibited the proliferation and induced the ferroptosis of hemangioma endothelial cells by regulating miR-497-5p/NOTCH2 axis. Importantly, silencing MEG8 significantly decreased the expressions of SLC7A11 and GPX4 both in mRNA and protein level and had no effect on the level of AIFM2. | |||
